SA Pharma Sector Unfazed by US Tariffs Impact
The SA pharma sector is unfazed by US tariffs, as key leaders assess the situation, ensuring stability and security in the market.
The SA pharma sector is unfazed by US tariffs, as key leaders assess the situation, ensuring stability and security in the market.
Insights from a KZN study reveal that casual contact drives TB, shifting the focus from close household exposure to community interactions.
SAMA challenges NHI Act, citing concerns over constitutionality and its potential impact on South Africa's healthcare system.
Explore the alarming increase in HIV cases as treatment coverage falters in South Africa. What does the future hold?
South African researchers face significant funding cuts from the US National Institutes of Health (NIH), jeopardising critical HIV/AIDS and TB research.